NIH-funded research R21 grant

Investigating how a specific enzyme affects lung cancer caused by airborne toxins

Official title: The role of DNA Polymerase Delta 4 in Lung Carcinogenesis Induced by Genotoxic Carcinogens

Funded at New York Medical College · NIH-11118840 · Data updated 2026-11-12

This study is looking at how a specific protein related to DNA repair might play a role in lung cancer caused by harmful substances in the air, and it hopes to find new ways to help prevent or treat lung cancer for people affected by these environmental factors.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionNew York Medical College
NIH-funded
Lab location1 site (Valhalla, United States)
Project startJune 18, 2024
Project endMay 31, 2026
Funding year2025
Award (this year)$247,500
NIH project number5R21ES036369-02
Project IDNIH-11118840 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have been exposed to airborne carcinogens and are at risk for developing lung cancer.

Less likely to help

Patients who do not have a history of exposure to airborne carcinogens or who have other unrelated forms of lung cancer may not benefit from this research.

What this research studies

This research focuses on understanding the role of DNA Polymerase Delta 4 in the development of lung cancer due to exposure to harmful airborne carcinogens. It examines how these carcinogens, such as benzo(a)pyrene, lead to DNA damage and potentially contribute to cancer formation. By studying the degradation of a specific protein involved in DNA repair, the research aims to uncover new insights into the mechanisms of lung carcinogenesis. Patients may benefit from this research as it could lead to improved prevention strategies or treatments for lung cancer linked to environmental exposures.

Why it matters

Potential benefit: If successful, this research could provide new strategies for preventing or treating lung cancer caused by environmental toxins.

How similar studies have gone: Other research has shown promising results in understanding the mechanisms of lung cancer related to DNA damage, making this approach both relevant and potentially impactful.

Where this research is happening

  • New York Medical College
    Valhalla, United States
    Active

Researchers

  • Principal investigator: Xu, Dazhong — New York Medical College
  • Study coordinator: Xu, Dazhong

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.